Marker Therapeutics Inc
NASDAQ:MRKR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Marker Therapeutics Inc
NASDAQ:MRKR
|
US |
|
Ameresco Inc
LSE:0A70
|
US |
|
G
|
Greenbrier Companies Inc
SWB:G90
|
US |
|
R
|
Redcare Pharmacy NV
DUS:RDC
|
NL |
|
CarGurus Inc
NASDAQ:CARG
|
US |
|
Zhejiang China Commodities City Group Co Ltd
SSE:600415
|
CN |
|
Credit Agricole SA
PAR:ACA
|
FR |
|
Kikkoman Corp
OTC:KIKOF
|
JP |
|
P
|
Puma SE
XHAM:PUM
|
DE |
|
Enphase Energy Inc
BMV:ENPH
|
US |
|
O
|
OFS Capital Corp
F:9UD
|
US |
|
Grifols SA
MAD:GRF
|
ES |
|
TechnoPro Holdings Inc
TSE:6028
|
JP |
|
U
|
Ubiquiti Inc
LSE:0LI9
|
US |
|
D
|
Dolby Laboratories Inc
XBER:FUO
|
US |
|
Transurban Group
ASX:TCL
|
AU |
|
D
|
DSV A/S
XBER:DS81
|
DK |
|
CDW Corp
NASDAQ:CDW
|
US |
|
NN Group NV
AEX:NN
|
NL |
|
Ivanhoe Mines Ltd
TSX:IVN
|
CA |
|
UDR Inc
NYSE:UDR
|
US |
|
Sun Life Financial Inc
TSX:SLF
|
CA |
|
I
|
Inversiones Aguas Metropolitanas SA
SGO:IAM
|
CL |
|
A
|
Absa Bank Ltd
JSE:ABSP
|
ZA |
Bankruptcy Probability
Marker Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Marker Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Marker Therapeutics Inc
NASDAQ:MRKR
|
21.9m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
449.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
197.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
123.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
71.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
46.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Marker Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Marker Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
